Health Benefits | PBM Consulting
Biosimilars could reduce pharmacy costs
Biologics represent a hefty portion of pharmaceutical spending in the U.S., yet more affordable biosimilars remain underutilized.
Read moreStay up to date on the issues impacting the industry and be the first to hear about news and changes at Rael & Letson.
Biologics represent a hefty portion of pharmaceutical spending in the U.S., yet more affordable biosimilars remain underutilized.
Read moreConsumer directed health (high deductible) plans combined with an HSA can allow participants more control over their health care dollars.
Read more